Advanced search
Publication Cover
Cancer Biology & Therapy Volume 25, 2024 - Issue 1
Submit an article Journal homepage
2,175
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer

Jianqing Qiua Department of Obstetrics and Gynecology, the Second Hospital of Shandong University, Jinan, PR, ChinaView further author information
,
Ziyi Zhaob Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;c Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital MedicalUniversity, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaView further author information
,
Hongyan Suob Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;c Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital MedicalUniversity, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaView further author information
,
Sarah E. Paraghamianb Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAView further author information
,
Gabrielle M. Hawkinsb Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAView further author information
,
Wenchuan Sunb Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAView further author information
,
Xin Zhangb Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;c Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital MedicalUniversity, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaView further author information
,
Tianran Haob Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAView further author information
,
Beor Dengb Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;c Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital MedicalUniversity, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaView further author information
,
Xiaochang Shenb Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;c Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital MedicalUniversity, Beijing Maternal and Child Health Care Hospital, Beijing, ChinaView further author information
,
Chunxiao Zhoub Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;d Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1257-9537View further author information
ORCID Icon &
Victoria Bae-Jumpb Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA;d Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USACorrespondence[email protected]
View further author information
 show all
Article: 2325130 | Received 31 Jul 2023, Accepted 26 Feb 2024, Published online: 11 Mar 2024

References

  • Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–11. doi:10.3322/caac.21763.
  • King L, Gajarawala S, McCrary MD. Endometrial cancer and obesity: addressing the awkward silence. Jaapa. 2023;36(1):28–31. doi:10.1097/01.JAA.0000902884.01725.a3.
  • Rundle-Thiele D, Shrestha S, Janda M. Prevention of endometrial cancer through lifestyle interventions: a systematic review and synthesis. Gynecol Oncol Rep. 2021;39:39. doi:10.1016/j.gore.2021.100900.
  • Kako TD, Kamal MZ, Dholakia J, Scalise CB, Arend RC. High-intermediate risk endometrial cancer: moving toward a molecularly based risk assessment profile. Int J Clin Oncol. 2022;27(2):323–331. doi:10.1007/s10147-021-02089-2.
  • Dexter J, Lips E, DiSilvestro P. Adjuvant therapy in node-positive endometrial cancer: a focus on chemotherapy. Curr Oncol Rep. 2022;24(12):1677–1683. doi:10.1007/s11912-022-01327-8.
  • Chen LC, Huang Y, Hou JY, Khoury-Collado F, Melamed A, St Clair CM, Tergas AI, Hur C, Hillyer GC, Hershman DL, et al. Toxicity after adjuvant therapy for stage III uterine cancer. Gynecol Oncol. 2020;159(3):737–743. doi:10.1016/j.ygyno.2020.09.033.
  • Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, Krakstad C, Werner HMJ, Amant F. Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification. Cancers. 2021;13(22):5848. doi:10.3390/cancers13225848.
  • de Carvalho C, Caramujo MJ. The various roles of fatty acids. Molecules. 2018;23(10):23. doi:10.3390/molecules23102583.
  • Calder PC. Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr. 2015;39(1S):18S–32S. doi:10.1177/0148607115595980.
  • Cunnane SC, Guesnet P. Linoleic acid recommendations—a house of cards. Prostaglandins Leukot Essent Fatty Acids. 2011;85(6):399–402. doi:10.1016/j.plefa.2011.09.003.
  • Whelan J, Fritsche K. Linoleic acid. Adv Nutr. 2013;4(3):311–2. doi:10.3945/an.113.003772.
  • Jandacek RJ. Linoleic Acid: A Nutritional Quandary. Healthcare. 2017;5(2):25. doi:10.3390/healthcare5020025.
  • Schwab U, Lauritzen L, Tholstrup T, Haldorssoni T, Riserus U, Uusitupa M, Becker W. Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food & Nutrit Res. 2014;58(1):58. doi:10.3402/fnr.v58.25145.
  • Ramsden CE, Zamora D, Majchrzak-Hong S, Faurot KR, Broste SK, Frantz RP, Davis JM, Ringel A, Suchindran CM, Hibbeln JR, et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota coronary experiment (1968-73). BMJ. 2016;12. doi:10.1136/bmj.i1246.
  • Li K, Sinclair AJ, Zhao F, Li D. Uncommon fatty acids and cardiometabolic health. Nutrients. 2018;10(10):10. doi:10.3390/nu10101559.
  • Ohmori H, Sasahira T, Fujii K, Yi L, Shimomoto T, Kuniyasu H. Linoleic-acid-induced growth suppression induces quiescent cancer cell nests in nude mice. Pathobiology. 2008;75(4):226–232. doi:10.1159/000132383.
  • Reyes N, Reyes I, Tiwari R, Geliebter J. Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Lett. 2004;209(1):25–35. doi:10.1016/j.canlet.2003.12.010.
  • Lu X, Yu H, Ma Q, Shen S, Das UN. Linoleic acid suppresses colorectal cancer cell growth by inducing oxidant stress and mitochondrial dysfunction. Lipids Health Dis. 2010;9(1):9–106. doi:10.1186/1476-511X-9-106.
  • Pink RC, Bailey TA, Iputo JE, Sammon AM, Woodman AC, Carter DR. Molecular basis for maize as a risk factor for esophageal cancer in a South African population via a prostaglandin E2 positive feedback mechanism. Nutr Cancer. 2011;63(5):714–721. doi:10.1080/01635581.2011.570893.
  • Kwon JI, Kim GY, Park KY, Ryu CH, Choi YH. Induction of apoptosis by linoleic acid is associated with the modulation of bcl-2 family and Fas/FasL system and activation of caspases in AGS human gastric adenocarcinoma cells. J Med Food. 2008;11(1):1–8. doi:10.1089/jmf.2007.073.
  • Serna-Marquez N, Villegas-Comonfort S, Galindo-Hernandez O, Navarro-Tito N, Millan A, Salazar EP. Role of LOXs and COX-2 on FAK activation and cell migration induced by linoleic acid in MDA-MB-231 breast cancer cells. Cell Oncol. 2013;36(1):65–77. doi:10.1007/s13402-012-0114-4.
  • Matsuoka T, Adair JE, Lih FB, Hsi LC, Rubino M, Eling TE, Tomer KB, Yashiro M, Hirakawa K, Olden K, et al. Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice. Br J Cancer. 2010;103(8):1182–1191. doi:10.1038/sj.bjc.6605881.
  • Ogata R, Mori S, Kishi S, Sasaki R, Iwata N, Ohmori H, Sasaki T, Nishiguchi Y, Nakashima C, Goto K, et al. Linoleic Acid Upregulates microRNA-494 to Induce Quiescence in Colorectal Cancer. Int J Mol Sci. 2021;23(1):23. doi:10.3390/ijms23010225.
  • Potischman N, Swanson CA, Brinton LA, McAdams M, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Hoover RN. Dietary associations in a case-control study of endometrial cancer. Cancer Causes Control. 1993;4(3):239–250. doi:10.1007/BF00051319.
  • Zhao J, Lyu C, Gao J, Du L, Shan B, Zhang H, Wang H-Y, Gao Y. Dietary fat intake and endometrial cancer risk: a dose response meta-analysis. Medicine (Baltimore). 2016;95(27):0000000000004121. doi:10.1097/MD.0000000000004121.
  • Gaudet MM, Falk RT, Stevens RD, Gunter MJ, Bain JR, Pfeiffer RM, Potischman N, Lissowska J, Peplonska B, Brinton LA, et al. Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. J Clin Endocr Metab. 2012; 97(9):3216–23. doi:10.1210/jc.2012-1490.
  • Cassidy A, De Vivo I, Liu Y, Han J, Prescott J, Hunter DJ, Rimm EB. Associations between diet, lifestyle factors, and telomere length in women. Am J Clinic Nurtrit. 2010;91(5):1273–1280. doi:10.3945/ajcn.2009.28947.
  • Troisi J, Sarno L, Landolfi A, Scala G, Martinelli P, Venturella R, Di Cello A, Zullo F, Guida M. Metabolomic signature of endometrial cancer. J Proteome Res. 2018;17(2):804–812. doi:10.1021/acs.jproteome.7b00503.
  • Gu M, Chen X, Sun Y, Wang L, Shu H, Qian C. A metabolomic signature of FIGO stage I and II endometrial cancer. Neoplasma. 2021;68(6):1283–1291. doi:10.4149/neo_2021_210306N288.
  • Altadill T, Dowdy TM, Gill K, Reques A, Menon SS, Moiola CP, Lopez-Gil C, Coll E, Matias-Guiu X, Cabrera S, et al. Metabolomic and lipidomic profiling identifies the role of the RNA editing pathway in endometrial carcinogenesis. Sci Rep. 2017; 7(1):8803. doi:10.1038/s41598-017-09169-2.
  • Gonzalez-Reyes C, Marcial-Medina C, Cervantes-Anaya N, Cortes-Reynosa P, Salazar EP. Migration and invasion induced by linoleic acid are mediated through fascin in MDA-MB-231 breast cancer cells. Mol Cell Biochem. 2018;443(1–2):1–10. doi:10.1007/s11010-017-3205-8.
  • Rodriguez-Monterrosas C, Diaz-Aragon R, Cortes-Reynosa P, Salazar EP. Linoleic acid induces an increased response to insulin in MDA-MB-231 breast cancer cells. J Cell Biochem. 2018;119(7):5413–5425. doi:10.1002/jcb.26694.
  • Mielczarek-Puta M, Otto-Ślusarczyk D, Chrzanowska A, Filipek A, Graboń W. Telmisartan influences the antiproliferative activity of linoleic acid in human colon cancer cells. Nutr Cancer. 2020. 72:98–109. doi:10.1080/01635581.2019.1613552.
  • Lu XF, He GQ, Yu HN, Ma Q, Shen SR, Das UN. Colorectal cancer cell growth inhibition by linoleic acid is related to fatty acid composition changes. J Zhejiang Univ Sci B. 2010;11(12):923–930. doi:10.1631/jzus.B1000125.
  • Zhang Y, Xue R, Zhang Z, Yang X, Shi H. Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells. Lipids Health Dis. 2012;11(1):11–1. doi:10.1186/1476-511X-11-1.
  • Leal-Esteban LC, Fajas L. Cell cycle regulators in cancer cell metabolism. Biochim Biophys Acta Mol Basis Dis. 2020;1(5):5. doi:10.1016/j.bbadis.2020.165715.
  • Mounier C, Bouraoui L, Rassart E. Lipogenesis in cancer progression (review). Int J Oncol. 2014;45(2):485–92. doi:10.3892/ijo.2014.2441.
  • Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122(1):4–22. doi:10.1038/s41416-019-0650-z.
  • Escoté X, Fajas L. Metabolic adaptation to cancer growth: from the cell to the organism. Cancer Lett. 2015;356(2):171–5. doi:10.1016/j.canlet.2014.03.034.
  • Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21(3):162–80. doi:10.1038/s41568-020-00320-2.
  • Espinosa-Neira R, Mejia-Rangel J, Cortes-Reynosa P, Salazar EP. Linoleic acid induces an EMT-like process in mammary epithelial cells MCF10A. Int J Biochem Cell Biol. 2011;43(12):1782–91. doi:10.1016/j.biocel.2011.08.017.
  • Al-Alwan M, Olabi S, Ghebeh H, Barhoush E, Tulbah A, Al-Tweigeri T, Ajarim D, Adra C. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules. PLoS One. 2011;6(11):e27339. doi:10.1371/journal.pone.0027339.
  • Sasaki T, Fujii K, Yoshida K, Shimura H, Sasahira T, Ohmori H, Kuniyasu H. Peritoneal metastasis inhibition by linoleic acid with activation of PPARγ in human gastrointestinal cancer cells. Virchows Arch. 2006;448(4):422–427. doi:10.1007/s00428-005-0110-4.
  • Chen HW, Chao CY, Lin LL, Lu CY, Liu KL, Lii CK, Li C-C. Inhibition of matrix metalloproteinase-9 expression by docosahexaenoic acid mediated by heme oxygenase 1 in 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast cancer cells. Arch Toxicol. 2013;87(5):857–869. doi:10.1007/s00204-012-1003-3.
  • Makker A, Goel MM. Tumor progression, metastasis, and modulators of epithelial–mesenchymal transition in endometrioid endometrial carcinoma: an update. Endocr Relat Cancer. 2016;23(2):R85–R111. doi:10.1530/ERC-15-0218.
  • Guo H, Kong W, Zhang L, Han J, Clark LH, Yin Y, Fang Z, Sun W, Wang J, Gilliam TP, et al. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin. Am J Cancer Res. 2019;9(10):2170–2193.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.